BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6851194)

  • 1. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
    Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
    Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
    Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
    Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
    J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased thyrotrophin and prolactin secretion induced by domperidone in hypothyroid subjects.
    Massara F; Camanni F; Amoroso A; Molinatti GM; Müller EE
    Acta Endocrinol (Copenh); 1981 May; 97(1):48-53. PubMed ID: 7223316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
    Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the role of dopamine receptors in the central regulation of human TSH.
    Delitala G; Devilla L; Canessa A; D'Asta F
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.
    Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K
    Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced dopaminergic inhibition of thyrotrophin release in states of physiological hyperprolactinaemia.
    Rodriguez-Arnao MD; Weightman DR; Hall R; Scanlon MF; Camporro JM; Gomez-Pan A
    Clin Endocrinol (Oxf); 1982 Jul; 17(1):15-9. PubMed ID: 7116653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential TSH and PRL responses to dopamine receptor blockade in acromegaly.
    Prescott RW; Weightman DR; Kendall-Taylor P; Johnston DG
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):369-75. PubMed ID: 6509782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia.
    Peters JR; Rodriguez-Arnao MD; Foord SM; Edwards C; Dieguez C; Woodhead S; Hall R; Scanlon MF
    J Endocrinol Invest; 1985 Apr; 8(2):163-6. PubMed ID: 4031383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
    Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL
    Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia.
    Pinto LP; Hanna FW; Evans LM; Davies JS; John R; Scanlon MF
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):580-4. PubMed ID: 14616880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
    Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute endocrine profile of sulpiride in the human.
    L'Hermite M; Denayer P; Golstein J; Virasoro E; Vanhaelst L; Copinschi G; Robyn C
    Clin Endocrinol (Oxf); 1978 Sep; 9(3):195-204. PubMed ID: 709890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
    Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
    Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sulpiride on plasma prolactin levels in women with puerperal or pathological hyperprolactinaemia.
    Massara F; Camanni F; Belforte L; Campagnoli C; Novi RF; Molinatti GM
    Acta Endocrinol (Copenh); 1980 Oct; 95(2):145-50. PubMed ID: 7435113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.